917 articles by Susan Kelly
-
Intuitive details launch plan for new da Vinci 5 robot
March 18, 2024 -
Intuitive lands FDA clearance for new da Vinci robot
March 15, 2024 -
QuidelOrtho to lay off employees after firing CEO
March 14, 2024 -
Abbott recalls Heartmate LVAD communication system
March 12, 2024 -
Former Stimwave CEO found guilty of selling fake implantable device component
March 8, 2024 -
Vicarious presses forward with soft tissue robot despite struggles
March 6, 2024 -
Haemonetics to buy Attune Medical for $160M
March 5, 2024 -
Boston Scientific gains FDA nod for drug-coated coronary balloon
March 1, 2024 -
Abbott leader on the ‘hype’ and ‘reality’ of pulsed field ablation
March 1, 2024 -
J&J’s pulsed field ablation system secures European approval
Feb. 29, 2024 -
J&J begins enrolling patients in Laminar LAA pivotal trial
Feb. 28, 2024 -
Integra Lifesciences to cut about 60 jobs as it closes Indiana site
Feb. 27, 2024 -
Agiliti to go private in $2.5B PE deal
Feb. 26, 2024 -
New GT Medical CEO Per Langoe on driving adoption of brain tumor therapy
Feb. 23, 2024 -
Agilent’s McDonnell to succeed retiring CEO McMullen
Feb. 22, 2024 -
UK medical device reviewers form new association
Feb. 20, 2024 -
Illumina cut 12% of global staff over past year: CEO
Feb. 9, 2024 -
Illumina to lay off 111 people at San Diego headquarters
Feb. 8, 2024 -
How Edwards’ Evoque valve won an early nod from the FDA
Feb. 7, 2024 -
Invitae hires advisers, considers bankruptcy: WSJ
Feb. 7, 2024 -
Nanostring files for bankruptcy protection, explores possible sale
Feb. 5, 2024 -
FDA to reclassify most high-risk IVDs, easing path to clearance
Feb. 5, 2024 -
Boston Scientific nets Farapulse approval, pushes back US TAVR launch
Jan. 31, 2024 -
4 heart device trends shaping the medtech sector in 2024
Jan. 30, 2024 -
Vicarious Surgical hires former Olympus leader as president
Jan. 30, 2024